Establishment Labs Holdings Inc (ESTA) reported better-than-expected financial results for the third quarter of fiscal 2025. The company posted an earnings per share (EPS) of $-0.38, surpassing Wall Street's consensus estimate of $-0.54 by $0.16. Revenue matched expectations at $0.1 billion.
The announcement highlights the company's operational resilience, as it continues to engage in the design, development, manufacture, and marketing of silicone breast implants. Headquartered in Alajuela, Costa Rica, Establishment Labs employs 1,056 full-time staff and has established a global footprint, selling its Motiva Implants brand in over 80 countries.
The company will host its earnings conference call to discuss these results and provide further insights into its business performance.
This update provides insight into Establishment Labs Holdings Inc's recent financial health, as exceeding analyst expectations may reflect stronger business fundamentals. Investors are encouraged to review the full earnings release and listen to management commentary for a comprehensive understanding of the quarter's performance and future outlook.
Looking ahead, the company is set to report its next earnings on August 4, 2026, with an EPS estimate of $-0.3158 and revenue forecasted at $0.1 billion.